In particular, the use of anti-inflammatory drugs, already reported in symptomatic GD patients [12] and drugs targeting pathways such as p38, already utilized in autoinflammatory conditions like rheumatoid arthritis and Crohn's disease [50,51], may find application in GD. This evidence concerns the gene MAPK14 and rheumatoid arthritis.